BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rajamohan N, Khasawneh H, Singh A, Suman G, Johnson GB, Majumder S, Halfdanarson TR, Goenka AH. PET/CT and PET/MRI in neuroendocrine neoplasms. Abdom Radiol (NY) 2022;47:4058-72. [PMID: 35426497 DOI: 10.1007/s00261-022-03516-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Fortunati E, Bonazzi N, Zanoni L, Fanti S, Ambrosini V. Molecular imaging Theranostics of Neuroendocrine Tumors. Semin Nucl Med 2023:S0001-2998(22)00115-5. [PMID: 36623974 DOI: 10.1053/j.semnuclmed.2022.12.007] [Reference Citation Analysis]
2 Virarkar MK, Montanarella M, Itani M, Calimano-ramirez L, Gopireddy D, Bhosale P. PET/MRI imaging in neuroendocrine neoplasm. Abdom Radiol 2022. [DOI: 10.1007/s00261-022-03757-1] [Reference Citation Analysis]
3 Torbenson M, Venkatesh SK, Halfdanarson TR, Navin PJ, Kamath P, Erickson LA. Primary Neuroendocrine Tumors and Primary Neuroendocrine Carcinomas of the Liver: A Proposal for a Multidiscipline Definition. Hum Pathol 2022:S0046-8177(22)00174-5. [PMID: 35809684 DOI: 10.1016/j.humpath.2022.07.001] [Reference Citation Analysis]
4 Farr KP, Moses D, Haghighi KS, Phillips PA, Hillenbrand CM, Chua BH. Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities. Cancers 2022;14:2539. [DOI: 10.3390/cancers14102539] [Reference Citation Analysis]